Indian Journal of Urology Users online:2384  
IJU
Home Current Issue Ahead of print Editorial Board Archives Symposia Guidelines Subscriptions Login 
Print this page  Email this page Small font sizeDefault font sizeIncrease font size


 
UROSCAN
Year : 2005  |  Volume : 21  |  Issue : 2  |  Page : 128-129
 

Alpha blockers or antibiotics in chronic prostatitis/ chronic pelvic pain syndrome - what is the evidence?


Department of Urology, Christian Medical College, Vellore, Tamil Nadu, India

Correspondence Address:
J Chandra Singh
Department of Urology, Christian Medical College,Vellore 632 004, Tamilnadu
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions

 

How to cite this article:
Chandra Singh J, Kekre NS. Alpha blockers or antibiotics in chronic prostatitis/ chronic pelvic pain syndrome - what is the evidence?. Indian J Urol 2005;21:128-9

How to cite this URL:
Chandra Singh J, Kekre NS. Alpha blockers or antibiotics in chronic prostatitis/ chronic pelvic pain syndrome - what is the evidence?. Indian J Urol [serial online] 2005 [cited 2019 Dec 6];21:128-9. Available from: http://www.indianjurol.com/text.asp?2005/21/2/128/19641


Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial. Alexander RB, Propert KJ, Schaeffer AJ, Landis JR, Nickel JC, O'Leary MP et al.


   Comments Top


This is a multicentric prospective randomized, double-blind trial[1] with a 2 x 2 factorial design to compare the efficacy of ciprofloxacin, tamsulosin, both or placebo for a duration of 6 weeks in men with chronic prostatitis /chronic pelvic pain syndrome (CP/CPPS). Primary diagnostic criterion was pain or discomfort in the pelvic region for at least 3 months. Severity of symptoms was assessed by the use of the National Institutes of Health Chronic Prostatitis Symptoms Index (NIH-CPSI). Permuted block randomization schedule was used and 49 subjects were assigned to each group. The sample size was obtained to detect a 4-point treatment difference in the NIH-CPSI total score between baseline and at 6 weeks. Participants were randomly assigned to receive placebo; ciprofloxacin 500 mg twice daily alone; tamsulosin 0.4 mg alone or a combination of both. NIH-CPSI score was used for assessment of response. The primary outcome was the change in the NIH-CPSI total score from baseline to 6 weeks. All the recruited subjects were accounted for. Though there was a modest improvement of approximately 3 to 6 points in all four groups, no significant difference in the primary outcome was seen for ciprofloxacin versus no ciprofloxacin (P=0.15) or tamsulosin versus no tamsulosin (P>0.2). At 12 weeks, no further significant changes were seen. Hence the authors conclude that use of ciprofloxacin or tamsulosin as empirical therapy for men with long-standing CP/CPPS and at least moderate symptoms was not supported by literature.

Earlier randomized trials to study the efficacy of antimicrobials have not consistently been shown to be useful.[2] Although approximately 90% of cases of chronic prostatitis were believed to be of nonbacterial etiology,[3] patients with prostatic symptoms have generally received empirical antimicrobial therapy. In a recent survey, nearly all urologists who responded reported treating at least 50% of their patients with prostatitis with antibiotics.[4] Traditional first-line treatment of prostatitis has been most effectively achieved with trimethoprim (TMP) or trimethoprim-sulfamethoxazole (TMP-SMX) and, more recently, with a fluoroquinolone, such as norfloxacin, ofloxacin, ciprofloxacin, or levofloxacin.[5]

As symptom complexes of chronic abacterial prostatitis and benign prostatic hyperplasia overlap in most men, investigators hypothesized that drug therapy for benign prostatic hyperplasia (such as finasteride and a-blockers) may help some men with chronic abacterial prostatitis.[6] Randomized trials in which alpha blockers have been shown to be effective had enrolled men who were naοve to alpha blockers.[7] The reason why the results of this trial[1] do not support the findings of earlier trials may be because most of the participants had been treated with various medications before enrolment.[1] a-Blockers might have a role in treating CP/CPPS and they seem to work best in men who are naοve to these agents, have moderate to severe symptoms, and who are willing to stay on therapy for >6 weeks.[8]

 
   References Top

1.Alexander RB, Propert KJ, Schaeffer AJ, Landis JR, Nickel JC, O'Leary MP et al. Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial. Ann Intern Med 2004;141:581-9.  Back to cited text no. 1    
2.Nickel JC, Downey J, Clark J, Casey RW, Pommerville PJ, Barkin J et al. Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial. Urology 2003;62:614-7.  Back to cited text no. 2    
3.de la Rosette JJ, Hubregtse MR, Meuleman EJ, Stolk-Engelaar MV, Debruyne FM.Diagnosis and treatment of 409 patients with prostatitis syndromes. Urology 1993;41:301-7.  Back to cited text no. 3  [PUBMED]  
4.McNaughton Collins M, Fowler FJ Jr, Elliott DB, Albertsen PC, Barry MJ. Diagnosing and treating chronic prostatitis: do urologists use the four-glass test? Urology 2000;55:403-7.  Back to cited text no. 4  [PUBMED]  [FULLTEXT]
5.Nickel J, Weidner W. Chronic prostatitis current concepts and antimicrobial therapy. Infect Urol 2000;13:S22-S28.  Back to cited text no. 5    
6.McNaughton Collins M, MacDonald R, Wilt TJ. Diagnosis and treatment of chronic abacterial prostatitis: a systematic review. Ann Intern Med 2000;133:367-81.  Back to cited text no. 6  [PUBMED]  
7.Nickel JC, Narayan P, McKay J, Doyle C. Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial. J Urol 2004;171:1594-7.  Back to cited text no. 7    
8.Nickel JC. The three As of chronic prostatitis therapy: antibiotics, alpha-blockers and anti-inflammatories. What is the evidence? BJU Int 2004;94:1230-3.  Back to cited text no. 8  [PUBMED]  [FULLTEXT]




 

Top
Print this article  Email this article
Previous article Next article

    

 
   Search
 
   Next article
   Previous article 
   Table of Contents
  
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Article in PDF (90 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  


    Comments
    References

 Article Access Statistics
    Viewed4634    
    Printed107    
    Emailed0    
    PDF Downloaded144    
    Comments [Add]    

Recommend this journal

HEALTHWARE INDIA